LB Pharmaceuticals Inc. (LBRX)

LB Pharmaceuticals Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Year Ending	Current	Dec 31, 2024	Dec 31, 2023
Debt / Equity Ratio	-0.04	-0.04	-
Debt / EBITDA Ratio	-0.12	-0.06	-
Debt / FCF Ratio	-0.09	-0.07	-
Quick Ratio	3.64	3.45	16.61
Interest Coverage	-	-	-0.56
Return on Equity (ROE)	28.33%	66.74%	18.20%
Return on Assets (ROA)	-	-188.17%	-13.74%
Return on Capital (ROIC)	32.87%	71.36%	33.00%
Return on Capital Employed (ROCE)	781.44%	-254.95%	-5.25%

Source: IPO financials are sourced from S-1 and S-1/A filings submitted to the Securities and Exchange Commission (SEC).